Metastatic Colon Cancer Clinical Trial
Official title:
Topical Tretinoin Prophylaxis for Anti-EGFR Induced Skin Toxicity in Metastatic Colorectal Cancer
The goal of this clinical trial is to learn if using topical tretinoin will help patients with colorectal cancer who are experiencing an acneiform rash as a side effect of their treatment. Researchers will compare the use of tretinoin on one side of the face to the use of a placebo on the other side of the face to see if there is an impact.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04186117 -
Development of Clinical and Biological Database in Colorectal Cancer
|
N/A | |
| Completed |
NCT05468892 -
Phase II Randomized Study Evaluating the Efficacy of Panitumumab (VEctibix ) and Trifluridine-Tipiracil (LOnsurf) in Pretreated RAS Wild Type Metastatic Colorectal Cancer Patients: the VELO Trial
|
Phase 2 | |
| Recruiting |
NCT02291744 -
A Phase Ⅱ Study of XELOX Chemotherapy With or Without Surgery of Primary Lesion for Colon Cancer Patients
|
Phase 2 | |
| Active, not recruiting |
NCT00986661 -
A Study to Assess PV-10 Chemoablation of Cancer of the Liver
|
Phase 1 | |
| Completed |
NCT03176485 -
Evaluation of Pathway Modulation by Raf, MEK, & Kinase Inhibitors
|
N/A | |
| Recruiting |
NCT05983367 -
A Study to Investigate Ompenaclid Combined With FOLFIRI Plus Bevacizumab in Advanced/Metastatic Colorectal Cancer
|
Phase 2 | |
| Recruiting |
NCT03730558 -
ZETA : Prospective Observational Study
|
||
| Recruiting |
NCT06180460 -
CALM: Managing Distress in Malignant Brain Cancer
|
N/A | |
| Active, not recruiting |
NCT03251378 -
A Multi-Center, Open-Label Study of Fruquintinib in Solid Tumors, Colorectal, and Breast Cancer
|
Phase 1 | |
| Recruiting |
NCT04737213 -
SGM-101 in Colorectal Lung Metastases
|
Phase 2 | |
| Recruiting |
NCT05714124 -
Liver Embolization Approaches for Tumor Management
|
||
| Recruiting |
NCT05396807 -
REVERT - taRgeted thErapy for adVanced colorEctal canceR paTients
|
N/A | |
| Active, not recruiting |
NCT02724202 -
Curcumin in Combination With 5FU for Colon Cancer
|
Early Phase 1 | |
| Withdrawn |
NCT03764137 -
Imaging With [89Zr]Panitumumab-PET/MRI in Patients With Newly Diagnosed Colorectal Cancer
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05848739 -
A Phase 1-2 of ST316 With Selected Advanced Unresectable and Metastatic Solid Tumors
|
Phase 1 | |
| Not yet recruiting |
NCT06202183 -
Exercise for Gut Microbiome in Patients With Young-Onset Colorectal Cancer Undergoing Chemotherapy: The COURAGE Trial
|
N/A | |
| Withdrawn |
NCT01936961 -
Study of Immunochemotherapy +/- Hypofractionated Radiation for Complete Response in Solid Tumors
|
N/A | |
| Completed |
NCT03415126 -
A Study of ASN007 in Patients With Advanced Solid Tumors
|
Phase 1 | |
| Completed |
NCT02834052 -
Pembrolizumab + Poly-ICLC in MRP Colon Cancer
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT06446557 -
De-scalation or swItch of Treatment According to Circulating tuMOr DNA Variation After 2 Cycles of Doublet Chemotherapy Plus Targeted Agent in Metastatic Unresectable Colorectal Cancer
|
Phase 3 |